KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gsk (GSK) Enterprise Value (2016 - 2025)

Historic Enterprise Value for Gsk (GSK) over the last 17 years, with Q3 2025 value amounting to -$4.8 billion.

  • Gsk's Enterprise Value rose 681.96% to -$4.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.8 billion, marking a year-over-year increase of 681.96%. This contributed to the annual value of -$5.4 billion for FY2024, which is 2303.09% up from last year.
  • Per Gsk's latest filing, its Enterprise Value stood at -$4.8 billion for Q3 2025, which was up 681.96% from -$5.7 billion recorded in Q2 2025.
  • Gsk's Enterprise Value's 5-year high stood at $3.7 billion during Q3 2021, with a 5-year trough of -$9.7 billion in Q4 2022.
  • In the last 5 years, Gsk's Enterprise Value had a median value of -$4.8 billion in 2023 and averaged -$3.5 billion.
  • In the last 5 years, Gsk's Enterprise Value soared by 102153.1% in 2021 and then plummeted by 115387.52% in 2023.
  • Gsk's Enterprise Value (Quarter) stood at $2.7 billion in 2021, then tumbled by 459.29% to -$9.7 billion in 2022, then increased by 27.54% to -$7.1 billion in 2023, then grew by 22.55% to -$5.5 billion in 2024, then grew by 11.76% to -$4.8 billion in 2025.
  • Its Enterprise Value was -$4.8 billion in Q3 2025, compared to -$5.7 billion in Q2 2025 and -$6.4 billion in Q1 2025.